Compare ARVN & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARVN | WRN |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 676.9M |
| IPO Year | 2018 | N/A |
| Metric | ARVN | WRN |
|---|---|---|
| Price | $13.48 | $3.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 2 |
| Target Price | ★ $18.14 | $4.88 |
| AVG Volume (30 Days) | 753.9K | ★ 2.4M |
| Earning Date | 02-11-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $312,300,000.00 | N/A |
| Revenue This Year | $10.55 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.86 | N/A |
| 52 Week Low | $5.90 | $0.90 |
| 52 Week High | $20.38 | $4.26 |
| Indicator | ARVN | WRN |
|---|---|---|
| Relative Strength Index (RSI) | 57.38 | 46.57 |
| Support Level | $12.88 | $2.97 |
| Resistance Level | $14.14 | $3.81 |
| Average True Range (ATR) | 0.70 | 0.32 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 67.89 | 12.40 |
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).